Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul:54:110-9.
doi: 10.1016/j.reprotox.2014.12.013. Epub 2014 Dec 29.

Effect of maternal exposure to endocrine disrupting chemicals on reproduction and mammary gland development in female Sprague-Dawley rats

Affiliations

Effect of maternal exposure to endocrine disrupting chemicals on reproduction and mammary gland development in female Sprague-Dawley rats

Fabiana Manservisi et al. Reprod Toxicol. 2015 Jul.

Abstract

The aim of the study is to determine whether low doses of "endocrine disrupting chemicals" (EDCs) affect the development and proliferative activity of the mammary glands (MGs). Adult parous/nulliparous female Sprague-Dawley (SD) rats were treated from post-natal day (PND) 1 until PND 180 with diethylphthalate (DEP), methylparaben (MPB), triclosan (TCS) and a mixture at doses comparable to human exposure. The doses (mg/kg b.w./day) were: DEP=0.173; MPB=0.105; TCS=0.05. EDC treatment resulted in mortality rates >20% in pups as early as lactation day 7. Significant morphological/histological changes were observed at the end of lactation in the MGs of EDC-treated dams. The total transcriptome profile as well as lactation-related genes in MGs also corroborate the morphological findings as more profound gene expression changes are present only at the weaning period. The study highlights the heightened sensitivity of the MGs during critical windows of exposure, particularly pregnancy and lactation, with an impact on pups' survival.

Keywords: Endocrine disruptors; Mammary glands; Rats; Windows of susceptibility.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Outline of generation and treatment of experimental animals. A: F0 generation corresponds to breeders of the studied animals (F1), treated from delivery until weaning of the pups. B: The F1 generation was divided into two groups: nulliparous females treated from PND 1 until PND 181and parous females treated from PND 1 until PND 181, mated at PND 97 and observed during their pregnancy and lactation of their offspring. the F2 generation. For each group, at LD 28 (PND 146), corresponding to the end of lactation for parous rats, three animals per experimental group were sacrificed and mammary glands analyzed. At PND 181 all females were sacrificed and mammary gland examined. Solid triangles (▼) represent conclusion of exposure and sacrifice of animals.
FIGURE 2
FIGURE 2
Representative morphological and histological features of hematoxylin and eosin-stained paraffin sections of nulliparous female Sprague Dawleys rats, sacrificed at PND 181. Both the vehicle control (A,B) and treated (in this case with MPB) groups (C, D) showed normal ducts, epithelia, and stroma
FIGURE 3
FIGURE 3
Mammary gland from “Dams at the end of lactation-LD 28” Sprague-Dawley rat, 21-weeks old, sacrificed at LD 28 (after the weaning of their pups). Olive oil control (A,100X), DEP (B, 100X), MPB (C, 100X), TCS (D, 100X), MIX (E, 100X).
FIGURE 4
FIGURE 4
Representative morphological and histological features of hematoxylin and eosin-stained paraffin sections of parous female Sprague Dawleys rats, sacrificed at PND 181. Both the vehicle control (A, B) and treated (in this case with DEP) groups (C,D) showed residual secretory content in the collapsed alveolar and ducts structures
FIGURE 5
FIGURE 5
Hierarchical clustering of significantly differentially expressed probe sets between TCS and OIL at PND 146 (LD 28) (FDR < 0.25, 1-way ANOVA). Yellow corresponds to up-regulated gene expression, blue to down-regulated gene expression.

Similar articles

Cited by

References

    1. World health Organization (WHO) Global Assessment of the State-of-the-Science of Endocrine Disruptors. International Programme on Chemical Safety (IPCS) 2002
    1. Schug TT, Janesick A, Blumberg B, Heindel JJ. Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol. 2011;127:204–15. - PMC - PubMed
    1. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30:293–342. - PMC - PubMed
    1. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR, Jr., Lee DH, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev. 2012;33:378–455. - PMC - PubMed
    1. Brisken C. Endocrine Disruptors and Breast Cancer. Chimia. 2008;62:406–9.

Publication types

MeSH terms